A hematology analyzer is a medical
device used to test blood and bone marrow samples to help diagnose and monitor
blood related conditions. It helps analyze parameters like white blood cell
count, red blood cell count, hemoglobin, hematocrit and platelet levels in
blood. The growing awareness and increasing diagnosis of blood disorders and
cancers has led to significant rise in demand for hematology analyzers
globally. Hematology analyzers are now vital medical instruments used in
laboratories and healthcare facilities to accurately profile a patient's blood
and aid physician diagnosis and treatment decisions.
The Global Hematology Analyzer Market is estimated to be valued at US$ 4.94 Bn in 2024 and is expected to
exhibit a CAGR of 7.3% over the
forecast period 2024 To 2031.
Rising geriatric population
susceptible to blood disorders is a key factor driving market growth. In
addition, technological advancements enabling compact, automated and high
throughput testing as well as growing investments by key players are fueling
adoption Hematology
Analyzer Market Trends worldwide.
Key Takeaways
Key players operating in the Hematology Analyzer Market are Boule Diagnostics
AB, Bio-Rad Laboratories, Danaher Corporation, Sysmex, Horiba Medical, Nihon
Kohden Corporation, Siemens AG, Shenzhen Mindray Bio-Medical Electronics Co.,
Ltd, Abbott, Drew Scientific, Diatron, EKF Diagnostics, F. Hoffmann-La Roche
Ltd, Cormay Diagnostics, AGD Biomedicals, Pioneer Impex, BIOGENIX INC. PVT.
LTD, and Drucker Diagnostics. These players are focusing on new product
launches, partnerships and geographic expansions to gain greater market share.
The growing prevalence of blood disorders and cancers as well as rising
geriatric population worldwide presents significant growth opportunities for
players in the hematology analyzer market. Emerging economies with large
patient populations also offer lucrative expansion opportunities. Furthermore,
incorporation of artificial intelligence and digital technologies in hematology
analyzers is expected to revolutionize diagnostics and drive future demand.
Key
Players
Key players are actively expanding
globally including in developing regions to tap higher growth opportunities.
They are also focusing on partnerships with established diagnostic
laboratories, clinics and hospitals to increase product access and sales
volumes. Several companies are in the process of setting up manufacturing
plants in high potential Asian and Latin American countries to further
strengthen their geographic footprint worldwide.
Market
Drivers
Rising geriatric population - The
elderly are more prone to develop blood cancers and disorders, thus driving
demand for frequent blood screening using hematology analyzers.
Technological advancements - Introduction of digital technologies, artificial
intelligence, compact sizes and high throughput capabilities in newer
generation analyzers is a key growth driver.
Market Restraints
High price of advanced hematology analyzers limits adoption - While basic
analyzers have lower costs, high-end analyzers incorporating latest features
are expensive restricting widespread installation.
Lack of skilled lab technicians in developing countries - Effective usage and
maintenance of advanced hematology analyzers requires trained technicians which
are lacking in many developing regions limiting market growth.
Segment
Analysis
The hematology analyzer market is
dominated by the fully-automated hematology analyzers sub segment. These
analyzers can perform multiparameter CBC tests along with differentiating blood
cell populations accurately and precisely in an automated fashion without much
human intervention. Such high automation reduces manual errors and makes the
whole process efficient. Fully-automated analyzers also have high throughput of
above 60 samples per hour which makes them a preferred choice for laboratories
processing large number of hematology samples on a daily basis. Other segments
like semi-automated and point-of-care hemaotology analyzers are finding increasing
applications but fully-automated analyzers dominate the market due to
advantages of high accuracy, precision and efficiency.
Global Analysis
The North America region dominates
the global hematology analyzer market currently. Major factors responsible are
presence of advanced healthcare infrastructure, availability of skilled lab
technicians and growing prevalence of blood disorders. The United States holds
majority of the market share in this region. However, Asia Pacific region is
poised to grow at the fastest rate during the forecast period. Improving
healthcare infrastructure, rising medical tourism coupled with growing
geriatric population and increasing per capita healthcare expenditure in
developing countries like China and India is driving the growth of hematology
analyzer market in Asia Pacific. Government initiatives to strengthen blood
banks and labs are also supporting the regional market growth.
Gets
More Insights on, Hematology
Analyzer Market
Explore
More on, Hematology
Analyzer Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry.
She specializes in writing well-researched articles from different industries,
including food and beverages, information and technology, healthcare, chemical
and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
Post a Comment